関節リウマチの罹患率の増加と新規迅速検査キットの商品化が世界市場を牽引する

Growing Incidence of Rheumatoid Arthritis and Commercialization of Novel Rapid test Kits will drive the global market

関節リウマチの市場報告書の範囲 Persistence Market Research社の調査レポート「関節リウマチの世界市場」は、機会や現在の市場環境を評価し、詳細な分析、市場に影響を与える対応セクションに関する最新情報... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Persistence Market Research パーシスタンスマーケットリサーチ	2023年3月16日	US$4,900 シングルユーザライセンスライセンス・価格情報注文方法はこちら	211	英語

目次
図表リスト

サマリー

関節リウマチの市場報告書の範囲

Persistence Market Research社の調査レポート「関節リウマチの世界市場」は、機会や現在の市場環境を評価し、詳細な分析、市場に影響を与える対応セクションに関する最新情報を提供します。この調査は、市場の促進要因、抑制要因、動向、機会を含む現在の市場力学に関する詳細な洞察を提供します。この市場調査の主な目的は、2023年〜2033年の予測期間中に市場がどのように推移するかについての独占情報を提示することです。

市場の成功的な成長のための重要な指標は、市場の前年比（YoY）成長分析、複合年間成長率（CAGR）を含むこの包括的なレポートで提示され、Persistence Market Research社の調査で網羅的に説明されています。この調査研究は、読者が関節リウマチ診断サービスの需要と調査期間中の定量的な開発機会を知るためのサポートとなります。

この調査は、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーなどの景観の株主にとって有益であり、関節リウマチ市場で繁栄するために適切なビジネス戦略を開発するのに役立ちます。関節リウマチ市場の株主、業界専門家、投資家、研究者、記者、ビジネス愛好家は、このPersistence Market Researchの調査で示された洞察と情報を活用できます。

市場統計、ならびに関節リウマチ市場のビジネスシナリオに影響を与えるマクロ経済変数だけでなくミクロ経済変数に関連する情報も、現在の研究に含まれています。市場の潜在的な発展に応じて、実質的な洞察も本レポートで遭遇することができます。さらに、本レポートで提出されたデータにより、業界のマイナーな企業や新規参入者は、市場で牽引力を発揮するために適切な企業選択をする際に役立つことができます。

主要な市場セグメント

Persistence Market Research社の関節リウマチ市場に関する調査レポートは、検査タイプ、エンドユーザー、地域の3つの重要なセグメントに分けて情報を提供しています。本レポートでは、これらのカテゴリーに関連する重要な市場力学と成長パラメータに関する包括的なデータと情報を提供します。

検査タイプ
血清学的検査
赤血球沈降速度(ESR)
リウマトイド因子(RF)
抗環状シトルリン化ペプチド(抗CCP)
抗核抗体(ANA)
尿酸
その他の検査
RA治療効率のモニタリング検査
サリチル酸濃度測定
筋酵素検査
クレアチニン検査
エンドユーザー
病院
診断ラボラトリー
民間検査機関
公的検査機関
外来手術センター
地域別
北アメリカ
ラテンアメリカ
ヨーロッパ
南アジア
東アジア
オセアニア
中東・アフリカ(MEA)
報告書に記載されている主な質問

今後数年間、関節リウマチの最も収益性の高い市場であり続けるのはどの地域か？
トレンドの変化は市場にどのような影響を与えるのか？
COVID-19危機は市場成長にどのような影響を与えたか？
市場関係者はどのようにして先進国の低空飛行の機会を獲得することができるのか？
市場関係者は、このランドスケープにおける自らのポジションを形成するために、どのような戦略を持っているのか？
投資家が市場に投資する際に認識する必要があり、取り組む可能性のある抑制要因とは？
市場に影響を与える発展的なトレンドは何ですか？
関節リウマチ市場の企業は、先進国や新興国における成長機会をどのように利用できるのか？
調査方法

Persistence Market Research社の調査レポートでは、関節リウマチ市場の成長に関する広範な調査を実施し、市場の将来の成長パラメータに関する結論を得るために、独自の調査手法を利用しています。この調査手法は、一次調査と二次調査の組み合わせであり、アナリストが結論の正確性と信頼性を確保するのに役立ちます。

市場調査の作成中にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは、一次資料として、本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行った。

一次および二次リソースから取得した包括的な情報は、市場内の企業からの検証として機能し、関節リウマチ市場の成長見通しに関するPersistence Market Researchの予測をより正確で信頼性の高いものにします。

ページTOPに戻る

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Innovation / Development Trends

4. Key Success Factors

4.1. Adoption Analysis

4.2. Key Regulations

4.3. Cost Analysis, By Test Type

4.4. Reimbursement Scenario

4.5. Supply Chain Analysis

4.6. PESTLE Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP outlook

5.1.2. Global Healthcare Outlook

5.1.3. Global Autoimmune Disease Diagnostics Market Outlook

5.2. Forecast Factors - Relevance & Impact

5.2.1. Growing Healthcare Expenditure

5.2.2. Increasing Adoption of Rheumatoid Arthritis Diagnostic Tests

5.2.3. Prevalence of Arthritis Diseases

5.2.4. New Product Launches

5.2.5. Adoption of Off-Label Arthritis Diagnostic Procedures

5.2.6. Increasing Research Activities to Expand Diagnostic Methods

5.2.7. Study of Limited Specificity and Sensitivity of Rheumatoid Arthritis Test Kits

5.2.8. Growing Awareness about Chronic Diseases

5.2.9. Government Funding and Initiatives

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis

6.1.1. By Test Type

6.1.2. By End User

6.1.3. By Country

6.2. 2022 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2014–2022 and Forecast, 2023–2033

7.1. Historical Market Value (US$ Mn) Analysis, 2014–2022

7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2014–2022 and Forecast 2023–2033, By Test Type

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Test Type, 2014–2022

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test Type, 2023–2033

8.3.1. Serology Test

8.3.1.1. Erythrocyte Sedimentation Rate (ESR)

8.3.1.2. Rheumatoid Factor (RF)

8.3.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP)

8.3.1.4. Antinuclear Antibody (ANA)

8.3.1.5. Uric Acid

8.3.1.6. Other Test

8.3.2. Monitoring RA Treatment Efficiency Tests

8.3.2.1. Salicylate Level Count

8.3.2.2. Muscle Enzyme Test

8.3.2.3. Creatinine Test

8.4. Market Attractiveness Analysis By Test Type

9. Global Market Analysis 2014–2022 and Forecast 2023–2033, By End User

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis by End User, 2014–2022

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2023–2033

9.3.1. Hospitals

9.3.2. Diagnostic Laboratories

9.3.2.1. Private Laboratories

9.3.2.2. Public Laboratories

9.3.3. Ambulatory Surgical Centers

9.4. Market Attractiveness Analysis by End User

10. Global Market Analysis 2014–2022 and Forecast 2023–2033, By Region

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis, by Region, 2014–2022

10.3. Current and Future Market Size (US$ Mn) Analysis Forecast by Region, 2023–2033

10.3.1. North America

10.3.2. Latin America

10.3.3. Europe

10.3.4. East Asia

10.3.5. South Asia

10.3.6. Oceania

10.3.7. Middle East & Africa

10.4. Market Attractiveness Analysis by Region

11. North America Market Analysis 2014–2022 and Forecast 2023–2033

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2014–2022

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

11.3.1. By Country

11.3.1.1. U.S.

11.3.1.2. Canada

11.3.2. By Test Type

11.3.3. By End User

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Test Type

11.4.3. By End User

11.5. Market Trends

11.6. Key Market Participants - Intensity Mapping

11.7. Drivers and Restraints - Impact Analysis

11.8. Country Level Analysis & Forecast

11.8.1. U.S. Market

11.8.1.1. Introduction

11.8.1.2. Market Analysis and Forecast by Market Taxonomy

11.8.1.2.1. By Test Type

11.8.1.2.2. By End User

11.8.2. Canada Market

11.8.2.1. Introduction

11.8.2.2. Market Analysis and Forecast by Market Taxonomy

11.8.2.2.1. By Test Type

11.8.2.2.2. By End User

12. Latin America Market Analysis 2014–2022 and Forecast 2023–2033

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2014–2022

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

12.3.1. By Country

12.3.1.1. Mexico

12.3.1.2. Brazil

12.3.1.3. Argentina

12.3.1.4. Rest of Latin America

12.3.2. By Test Type

12.3.3. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Test Type

12.4.3. By End User

12.5. Market Trends

12.6. Key Market Participants - Intensity Mapping

12.7. Drivers and Restraints - Impact Analysis

12.8. Country Level Analysis & Forecast

12.8.1. Mexico Market Analysis

12.8.1.1. Introduction

12.8.1.2. Market Analysis and Forecast by Market Taxonomy

12.8.1.2.1. By Test Type

12.8.1.2.2. By End User

12.8.2. Brazil Market Analysis

12.8.2.1. Introduction

12.8.2.2. Market Analysis and Forecast by Market Taxonomy

12.8.2.2.1. By Test Type

12.8.2.2.2. By End User

12.8.3. Argentina Market Analysis

12.8.3.1. Introduction

12.8.3.2. Market Analysis and Forecast by Market Taxonomy

12.8.3.2.1. By Test Type

12.8.3.2.2. By End User

13. Europe Market Analysis 2014–2022 and Forecast 2023–2033

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2014–2022

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

13.3.1. By Country

13.3.1.1. Germany

13.3.1.2. Italy

13.3.1.3. France

13.3.1.4. U.K.

13.3.1.5. Spain

13.3.1.6. BENELUX

13.3.1.7. Russia

13.3.1.8. Rest of Europe

13.3.2. By Test Type

13.3.3. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Test Type

13.4.3. By End User

13.5. Market Trends

13.6. Key Market Participants - Intensity Mapping

13.7. Drivers and Restraints - Impact Analysis

13.8. Country Level Analysis & Forecast

13.8.1. Germany Market Analysis

13.8.1.1. Introduction

13.8.1.2. Market Analysis and Forecast by Market Taxonomy

13.8.1.2.1. By Test Type

13.8.1.2.2. By End User

13.8.2. Italy Market Analysis

13.8.2.1. Introduction

13.8.2.2. Market Analysis and Forecast by Market Taxonomy

13.8.2.2.1. By Test Type

13.8.2.2.2. By End User

13.8.3. France Market Analysis

13.8.3.1. Introduction

13.8.3.2. Market Analysis and Forecast by Market Taxonomy

13.8.3.2.1. By Test Type

13.8.3.2.2. By End User

13.8.4. U.K. Market Analysis

13.8.4.1. Introduction

13.8.4.2. Market Analysis and Forecast by Market Taxonomy

13.8.4.2.1. By Test Type

13.8.4.2.2. By End User

13.8.5. Spain Market Analysis

13.8.5.1. Introduction

13.8.5.2. Market Analysis and Forecast by Market Taxonomy

13.8.5.2.1. By Test Type

13.8.5.2.2. By End User

13.8.6. BENELUX Market Analysis

13.8.6.1. Introduction

13.8.6.2. Market Analysis and Forecast by Market Taxonomy

13.8.6.2.1. By Test Type

13.8.6.2.2. By End User

13.8.7. Russia Market Analysis

13.8.7.1. Introduction

13.8.7.2. Market Analysis and Forecast by Market Taxonomy

13.8.7.2.1. By Test Type

13.8.7.2.2. By End User

14. East Asia Market Analysis 2014–2022 and Forecast 2023–2033

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2014–2022

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

14.3.1. By Country

14.3.1.1. China

14.3.1.2. Japan

14.3.1.3. South Korea

14.3.2. By Test Type

14.3.3. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Test Type

14.4.3. By End User

14.5. Market Trends

14.6. Key Market Participants - Intensity Mapping

14.7. Drivers and Restraints - Impact Analysis

14.8. Country Level Analysis & Forecast

14.8.1. China Market Analysis

14.8.1.1. Introduction

14.8.1.2. Market Analysis and Forecast by Market Taxonomy

14.8.1.2.1. By Test Type

14.8.1.2.2. By End User

14.8.2. Japan Market Analysis

14.8.2.1. Introduction

14.8.2.2. Market Analysis and Forecast by Market Taxonomy

14.8.2.2.1. By Test Type

14.8.2.2.2. By End User

14.8.3. South Korea Market Analysis

14.8.3.1. Introduction

14.8.3.2. Market Analysis and Forecast by Market Taxonomy

14.8.3.2.1. By Test Type

14.8.3.2.2. By End User

15. South Asia Market Analysis 2014–2022 and Forecast 2023–2033

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2014–2022

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

15.3.1. By Country

15.3.1.1. India

15.3.1.2. Indonesia

15.3.1.3. Malaysia

15.3.1.4. Thailand

15.3.1.5. Rest of South Asia

15.3.2. By Test Type

15.3.3. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Test Type

15.4.3. By End User

15.5. Market Trends

15.6. Key Market Participants - Intensity Mapping

15.7. Drivers and Restraints - Impact Analysis

15.8. Country Level Analysis & Forecast

15.8.1. India Market Analysis

15.8.1.1. Introduction

15.8.1.2. Market Analysis and Forecast by Market Taxonomy

15.8.1.2.1. By Test Type

15.8.1.2.2. By End User

15.8.2. Indonesia Market Analysis

15.8.2.1. Introduction

15.8.2.2. Market Analysis and Forecast by Market Taxonomy

15.8.2.2.1. By Test Type

15.8.2.2.2. By End User

15.8.3. Malaysia Market Analysis

15.8.3.1. Introduction

15.8.3.2. Market Analysis and Forecast by Market Taxonomy

15.8.3.2.1. By Test Type

15.8.3.2.2. By End User

15.8.4. Thailand Market Analysis

15.8.4.1. Introduction

15.8.4.2. Market Analysis and Forecast by Market Taxonomy

15.8.4.2.1. By Test Type

15.8.4.2.2. By End User

16. Oceania Market 2014-2022 and Forecast 2023-2033

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2014–2022

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

16.3.1. By Country

16.3.1.1. Australia

16.3.1.2. New Zealand

16.3.2. By Test Type

16.3.3. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Test Type

16.4.3. By End User

16.5. Market Trends

16.6. Key Market Participants - Intensity Mapping

16.7. Drivers and Restraints - Impact Analysis

16.8. Country Level Analysis & Forecast

16.8.1. Australia Market Analysis

16.8.1.1. Introduction

16.8.1.2. Market Analysis and Forecast by Market Taxonomy

16.8.1.2.1. By Test Type

16.8.1.2.2. By End User

16.8.2. New Zealand Market Analysis

16.8.2.1. Introduction

16.8.2.2. Market Analysis and Forecast by Market Taxonomy

16.8.2.2.1. By Test Type

16.8.2.2.2. By End User

17. Middle East and Africa (MEA) Market Analysis 2014–2022 and Forecast 2023–2033

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2014–2022

17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

17.3.1. By Country

17.3.1.1. GCC Countries

17.3.1.2. Türkiye

17.3.1.3. North Africa

17.3.1.4. South Africa

17.3.1.5. Rest of Middle East and Africa

17.3.2. By Test Type

17.3.3. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Test Type

17.4.3. By End User

17.5. Market Trends

17.6. Key Market Participants - Intensity Mapping

17.7. Drivers and Restraints - Impact Analysis

17.8. Country Level Analysis & Forecast

17.8.1. GCC Countries Market Analysis

17.8.1.1. Introduction

17.8.1.2. Market Analysis and Forecast by Market Taxonomy

17.8.1.2.1. By Test Type

17.8.1.2.2. By End User

17.8.2. Türkiye Market Analysis

17.8.2.1. Introduction

17.8.2.2. Market Analysis and Forecast by Market Taxonomy

17.8.2.2.1. By Test Type

17.8.2.2.2. By End User

17.8.3. South Africa Market Analysis

17.8.3.1. Introduction

17.8.3.2. Market Analysis and Forecast by Market Taxonomy

17.8.3.2.1. By Test Type

17.8.3.2.2. By End User

17.8.4. North Africa Market Analysis

17.8.4.1. Introduction

17.8.4.2. Market Analysis and Forecast by Market Taxonomy

17.8.4.2.1. By Test Type

17.8.4.2.2. By End User

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies

18.2. Market Share Analysis of Top Players

18.3. Market Presence Analysis

19. Competition Analysis

19.1. Competition Dashboard

19.2. Branding and Promotional Strategies

19.3. Key Development Analysis

19.4. Competition Deep Dive

19.4.1. Abbott Diagnostics

19.4.1.1. Overview

19.4.1.2. Service Portfolio

19.4.1.3. Sales Footprint

19.4.1.4. Key Financials

19.4.1.5. SWOT Analysis

19.4.1.6. Strategy Overview

19.4.1.6.1. Marketing Strategy

19.4.1.6.2. Diagnostic Test Strategy

19.4.1.6.3. Channel Strategy

19.4.2. Antibodies Incorporated

19.4.2.1. Overview

19.4.2.2. Service Portfolio

19.4.2.3. Sales Footprint

19.4.2.4. Key Financials

19.4.2.5. SWOT Analysis

19.4.2.6. Strategy Overview

19.4.2.6.1. Marketing Strategy

19.4.2.6.2. Diagnostic Test Strategy

19.4.2.6.3. Channel Strategy

19.4.3. Beckman Coulter, Inc.

19.4.3.1. Overview

19.4.3.2. Service Portfolio

19.4.3.3. Sales Footprint

19.4.3.4. Key Financials

19.4.3.5. SWOT Analysis

19.4.3.6. Strategy Overview

19.4.3.6.1. Marketing Strategy

19.4.3.6.2. Diagnostic Test Strategy

19.4.3.6.3. Channel Strategy

19.4.4. Euro Diagnostica AB

19.4.4.1. Overview

19.4.4.2. Service Portfolio

19.4.4.3. Sales Footprint

19.4.4.4. Key Financials

19.4.4.5. SWOT Analysis

19.4.4.6. Strategy Overview

19.4.4.6.1. Marketing Strategy

19.4.4.6.2. Diagnostic Test Strategy

19.4.4.6.3. Channel Strategy

19.4.5. Thermo Fisher Scientific Inc.

19.4.5.1. Overview

19.4.5.2. Service Portfolio

19.4.5.3. Sales Footprint

19.4.5.4. Key Financials

19.4.5.5. SWOT Analysis

19.4.5.6. Strategy Overview

19.4.5.6.1. Marketing Strategy

19.4.5.6.2. Diagnostic Test Strategy

19.4.5.6.3. Channel Strategy

19.4.6. Qiagen N.V.

19.4.6.1. Overview

19.4.6.2. Service Portfolio

19.4.6.3. Sales Footprint

19.4.6.4. Key Financials

19.4.6.5. SWOT Analysis

19.4.6.6. Strategy Overview

19.4.6.6.1. Marketing Strategy

19.4.6.6.2. Diagnostic Test Strategy

19.4.6.6.3. Channel Strategy

19.4.7. F. Hoffmann-La Roche Ltd.

19.4.7.1. Overview

19.4.7.2. Service Portfolio

19.4.7.3. Sales Footprint

19.4.7.4. Key Financials

19.4.7.5. SWOT Analysis

19.4.7.6. Strategy Overview

19.4.7.6.1. Marketing Strategy

19.4.7.6.2. Diagnostic Test Strategy

19.4.7.6.3. Channel Strategy

19.4.8. Siemens Healthcare GmbH

19.4.8.1. Overview

19.4.8.2. Service Portfolio

19.4.8.3. Sales Footprint

19.4.8.4. Key Financials

19.4.8.5. SWOT Analysis

19.4.8.6. Strategy Overview

19.4.8.6.1. Marketing Strategy

19.4.8.6.2. Diagnostic Test Strategy

19.4.8.6.3. Channel Strategy

19.4.9. Janel Group (Antibodies Inc.)

19.4.9.1. Overview

19.4.9.2. Service Portfolio

19.4.9.3. Sales Footprint

19.4.9.4. Key Financials

19.4.9.5. SWOT Analysis

19.4.9.6. Strategy Overview

19.4.9.6.1. Marketing Strategy

19.4.9.6.2. Diagnostic Test Strategy

19.4.9.6.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology

ページTOPに戻る

図表リスト

Table 1: Global Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 By Test Type

Table 2: Global Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by End User

Table 3: Global Rheumatoid Arthritis Market Analysis 2014–2022 and Forecast 2023–2033, by Region

Table 4: North America Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by Country

Table 5: North America Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 By Test Type

Table 6: North America Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by End User

Table 7: Latin America Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by Country

Table 8: Latin America Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 By Test Type

Table 9: Latin America Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by End User

Table 10: Europe Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by Country

Table 11: Europe Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 By Test Type

Table 12: Europe Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by End User

Table 13: East Asia Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by Country

Table 14: East Asia Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 By Test Type

Table 15: East Asia Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by End User

Table 16: South Asia Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by Country

Table 17: South Asia Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 By Test Type

Table 18: South Asia Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by End User

Table 19: Oceania Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by Country

Table 20: Oceania Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 By Test Type

Table 21: Oceania Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by End User

Table 22: Middle East & Africa Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by Country

Table 23: Middle East & Africa Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 By Test Type

Table 24: Middle East & Africa Rheumatoid Arthritis Market Value (US$ Mn) Analysis 2014–2022 and Forecast 2023–2033 by End User

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Rheumatoid Arthritis Market: Scope of the Report

The latest publication by Persistence Market Research on the global rheumatoid arthritis market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023 – 2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for rheumatoid arthritis diagnostic services and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the rheumatoid arthritis market. Shareholders in the rheumatoid arthritis market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro as well as microeconomic variables affecting the business scenario in the rheumatoid arthritis market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the rheumatoid arthritis market offers information divided into three important segments -test type, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Test Type
Serology Tests
Erythrocyte Sedimentation Rate (ESR)
Rheumatoid Factor (RF)
Anti–cyclic Citrullinated Peptide (anti–CCP)
Antinuclear Antibody (ANA)
Uric Acid
Other Test
Monitoring RA Treatment Efficiency Tests
Salicylate Level Count
Muscle Enzyme Test
Creatinine Test
End User
Hospitals
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Ambulatory Surgical Centers
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for rheumatoid arthritis over the coming years?
How will changing trends influence the market?
How has the COVID-19 crisis influenced market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will influence the market?
How can companies in the rheumatoid arthritis market avail themselves of the growth opportunities in developed and emerging sectors?
Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the rheumatoid arthritis market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the rheumatoid arthritis market are more accurate and reliable.

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

Persistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート

本レポートと同じKEY WORD（rheumatoid arthritis）の最新刊レポート

自動注射器の市場規模、シェア、動向分析：タイプ別（使い捨て、再利用可能）、適応疾患別（関節リウマチ、多発性硬化症）、最終用途別、地域別、セグメント別予測、2024年～2030年

よくあるご質問

Persistence Market Research社はどのような調査会社ですか?

パーシスタンスマーケットリサーチ（Persistence Market Research/PMR）は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

関節リウマチの罹患率の増加と新規迅速検査キットの商品化が世界市場を牽引する

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

Persistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート

本レポートと同じKEY WORD（rheumatoid arthritis）の最新刊レポート

よくあるご質問

Persistence Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?